ArticleNPJ precision oncology2026
Robust multicentre detection and classification of colorectal liver metastases on CT: application of foundation models.
Article in NPJ precision oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colorectal liver metastases (CRLM) remain a major cause of cancer-related mortality. Early, reliable detection on CT imaging is essential for curative treatment planning, yet the diagnostic performance of AI models often declines across scanners and institutions, limiting clinical generalizability. In this study, we developed and evaluated a multi-center foundation-model-based AI pipeline for patient-level classification and lesion-level detection of CRLM on contrast-enhanced CT. Using data from the EuCanImage consortium (n = 2437) and TCIA_CRLM (n = 197, all CRLM), we benchmarked several pretrained foundation models and identified UMedPT as the optimal encoder. The final model achieved an AUC of 0.89 and a sensitivity of 0.82 on the EuCanImage test set, with a sensitivity of 0.85 on the external TCIA cohort. Excluding the most uncertain 20% of cases improved AUC to 0.90 and balanced accuracy to 0.85. Decision-curve analysis indicated superior net benefit over "treat-all" and "treat-none" strategies for threshold probabilities between 0.35 and 0.75. The lesion-level detector identified 69.1% of lesions overall, increasing substantially with lesion size. Grad-CAM maps showed strong correspondence between attention regions and metastases in high-confidence predictions. These findings demonstrate that foundation-model-based pipelines enable robust, generalizable, and interpretable solutions for CRLM detection and classification in multi-center CT imaging.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.